|
81 |
Ein monoklonaler Antikörper gegen PACAP zur Migräneprophylaxe
Enthalten in Psychopharmakotherapie Bd. 32, 2025, Nr. 1: 42-43
|
|
|
|
82 |
Efficacy and Safety of GutGard ® in Managing Gastroesophageal Reflux-Related Symptoms: A Phase III, Single-Centre, Double-Blind, Randomized Placebo-Controlled Trial
Enthalten in Complementary medicine research Bd. 32, 2025, Nr. 1: 26-36. 11 S.
|
|
|
|
83 |
Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response
Enthalten in European addiction research Bd. 31, 2025, Nr. 4: 251-263. 13 S.
|
|
|
|
84 |
Effect of Topical Intra-Auricular Lidocaine on Tinnitus: A Randomized Double-Blind Placebo-Controlled Study
Enthalten in International archives of otorhinolaryngology Bd. 29, 2025, Nr. 04: 001-011
|
|
|
|
85 |
Kommunikationsstrategien: Placebo fördern und Nocebo vermeiden
Enthalten in Muskuloskelettale Physiotherapie Bd. 29, 2025, Nr. 01: 8-8
|
|
|
|
86 |
Erwartungseffekte im psychosozialen Behandlungskontext: Mechanismen und klinische Implikationen von Placebo- und Noceboeffekten beim Bauchschmerz
Enthalten in Balint-Journal Bd. 26, 2025, Nr. 01: 14-21
|
|
|
|
87 |
Is it personality or genes? – A secondary analysis on a randomized controlled trial investigating responsiveness to placebo analgesia
Enthalten in Scandinavian journal of pain Bd. 25, 2025, Nr. 1. 13 S.
|
|
|
|
88 |
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover study
Enthalten in Scandinavian journal of pain Bd. 25, 2025, Nr. 1. 12 S.
|
|
|
|
89 |
Zwischen Ethik und Wohlergehen – Der Placeboeffekt in der Physiotherapie
Enthalten in Physiopraxis Bd. 23, 2025, Nr. 02: 26-28
|
|
|
|
90 |
Clinical Effects of Lactobacillus reuteri on Gingival Inflammation and Alveolar Bone Loss in Periodontitis
Enthalten in Oral health & preventive dentistry Bd. 23, 2025, Nr. 1: 585-591
|
|
Administration
